Drug Information

Drug General Information
Drug ID
D00PDI
Former ID
DNC012525
Drug Name
N-[2-(5-Hydroxy-1H-indol-3-yl)-ethyl]-acetamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [534186]
Structure
Formula
C12H14N2O2
Canonical SMILES
CC(=O)NCCC1=CNC2=C1C=C(C=C2)O
InChI
1S/C12H14N2O2/c1-8(15)13-5-4-9-7-14-12-3-2-10(16)6-11(9)12/h2-3,6-7,14,16H,4-5H2,1H3,(H,13,15)
InChIKey
MVAWJSIDNICKHF-UHFFFAOYSA-N
PubChem Compound ID
903
Target and Pathway
Target(s) Melatonin receptor Target Info Inhibitor [534186]
KEGG Pathway Neuroactive ligand-receptor interaction
Circadian entrainment
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 534186J Med Chem. 1996 Aug 2;39(16):3089-95.Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.
Ref 534186J Med Chem. 1996 Aug 2;39(16):3089-95.Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.